These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2064418

  • 1. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC, Guerry D, Elder DE, Clark WH, Synnestvedt M, Norman S, Ayerle R.
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [Abstract] [Full Text] [Related]

  • 2. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L, Barnhill RL, Duray PH, Ernstoff MS, Kirkwood JM.
    Cancer Epidemiol Biomarkers Prev; 1993 Jul; 2(2):99-101. PubMed ID: 8467253
    [Abstract] [Full Text] [Related]

  • 3. Dysplastic nevi and other risk markers for melanoma.
    Seykora J, Elder D.
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [Abstract] [Full Text] [Related]

  • 4. Dysplastic nevi in association with multiple primary melanoma.
    Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM.
    Cancer Res; 1988 Feb 15; 48(4):1016-8. PubMed ID: 3338073
    [Abstract] [Full Text] [Related]

  • 5. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J, Pressley Z, Veledar E, Washington C, Chen SC.
    J Am Acad Dermatol; 2007 Sep 15; 57(3):428-34. PubMed ID: 17624623
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS, Moore DH, Sagebiel RW.
    Arch Dermatol; 1994 Aug 15; 130(8):1002-7. PubMed ID: 8053695
    [Abstract] [Full Text] [Related]

  • 7. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM, Martinez M, Tucker MA, Demenais F.
    Cancer Epidemiol Biomarkers Prev; 2000 Sep 15; 9(9):889-94. PubMed ID: 11008905
    [Abstract] [Full Text] [Related]

  • 8. Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.
    Hartge P, Holly EA, Halpern A, Sagebiel R, Guerry D, Elder D, Clark W, Hanson L, Harrison C, Tarone R.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep 15; 4(1):37-40. PubMed ID: 7894322
    [Abstract] [Full Text] [Related]

  • 9. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
    Barnhill RL, Kiryu H, Sober AJ, Mihm MC.
    Arch Dermatol; 1990 Apr 15; 126(4):463-5. PubMed ID: 2321991
    [Abstract] [Full Text] [Related]

  • 10. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H, Tóth-Molnár E, Oláh J, Dobozy A.
    Magy Onkol; 2005 Apr 15; 49(1):15-8. PubMed ID: 15902328
    [Abstract] [Full Text] [Related]

  • 11. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
    Duray PH, Ernstoff MS.
    Arch Dermatol; 1987 Jan 15; 123(1):80-4. PubMed ID: 3800426
    [Abstract] [Full Text] [Related]

  • 12. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
    Nagore E, Botella-Estrada R, Garcia-Casado Z, Requena C, Serra-Guillen C, Llombart B, Sanmartin O, Guillen C.
    J Eur Acad Dermatol Venereol; 2008 Aug 15; 22(8):931-6. PubMed ID: 18355200
    [Abstract] [Full Text] [Related]

  • 13. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.
    Weis E, Shah CP, Lajous M, Shields JA, Shields CL.
    Ophthalmology; 2009 Mar 15; 116(3):536-543.e2. PubMed ID: 19167086
    [Abstract] [Full Text] [Related]

  • 14. Use of host factors to identify people at high risk for cutaneous malignant melanoma .
    Marrett LD, King WD, Walter SD, From L.
    CMAJ; 1992 Aug 15; 147(4):445-53. PubMed ID: 1498755
    [Abstract] [Full Text] [Related]

  • 15. Grading of atypia in nevi: correlation with melanoma risk.
    Arumi-Uria M, McNutt NS, Finnerty B.
    Mod Pathol; 2003 Aug 15; 16(8):764-71. PubMed ID: 12920220
    [Abstract] [Full Text] [Related]

  • 16. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
    Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry D, Clark WH.
    JAMA; 1997 May 14; 277(18):1439-44. PubMed ID: 9145715
    [Abstract] [Full Text] [Related]

  • 17. Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over).
    Nagore E, Hueso L, Botella-Estrada R, Alfaro-Rubio A, Serna I, Guallar J, González I, Ribes I, Guillen C.
    J Eur Acad Dermatol Venereol; 2010 Jan 14; 24(1):50-7. PubMed ID: 19563496
    [Abstract] [Full Text] [Related]

  • 18. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):998-1007. PubMed ID: 15998953
    [Abstract] [Full Text] [Related]

  • 19. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
    van Hees CL, de Boer A, Jager MJ, Bleeker JC, Kakebeeke HM, Crijns MB, Vandenbroucke JP, Bergman W.
    J Invest Dermatol; 1994 Aug 06; 103(2):202-5. PubMed ID: 8040610
    [Abstract] [Full Text] [Related]

  • 20. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
    Marghoob AA, Kopf AW, Rigel DS, Bart RS, Friedman RJ, Yadav S, Abadir M, Sanfilippo L, Silverman MK, Vossaert KA.
    Arch Dermatol; 1994 Aug 06; 130(8):993-8. PubMed ID: 8053716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.